Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -65.29% is 2075673% below its 5-year average of 0.00%, around the middle of its 5-year range (-178.91%–19.42%).
19.54% below its 12-month average of -54.62%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -21.55%.
NET PROFIT MARGIN
-65.29%
NET PROFIT MARGIN AVG TTM
-54.62%
NET PROFIT MARGIN AVG 3Y
-7.35%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-19.54%
CURRENT VS 3Y AVG
-788.81%
CURRENT VS 5Y AVG
-2075672.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 623 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$37.15M
Net Profit Margin
-974.68%
TTM Avg
-561.03%
3Y Avg
-287.02%
5Y Avg
-224.14%
Market Cap
$36.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
Market Cap
$37.23M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-322.60%
Market Cap
$35.70M
Net Profit Margin
-12.24%
TTM Avg
-6.29%
3Y Avg
-4.54%
5Y Avg
-3.49%
Market Cap
$34.80M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$38.71M
Net Profit Margin
0.00%
TTM Avg
-27258.72%
3Y Avg
-52085.61%
5Y Avg
-35139.97%
Market Cap
$34.48M
Net Profit Margin
426.93%
TTM Avg
106.45%
3Y Avg
-19.31%
5Y Avg
-30.13%
Market Cap
$33.93M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1673.30%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DocGo Inc. (DCGO) | $36.48M | -65.29% | -54.62% | -7.35% | 0.00% |
| iTonic Holdings Ltd. (ITOC)vs › | $37.15M | -974.68% | -561.03% | -287.02% | -224.14% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.13M | 0.00% | 0.00% | 0.00% | -479.12% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.23M | 0.00% | 0.00% | 0.00% | -322.60% |
| Accuray Incorporated (ARAY)vs › | $35.70M | -12.24% | -6.29% | -4.54% | -3.49% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.80M | 0.00% | 0.00% | 0.00% | 0.00% |
| Incannex Healthcare Limited (IXHL)vs › | $38.71M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
| Elutia Inc (ELUT)vs › | $34.48M | 426.93% | 106.45% | -19.31% | -30.13% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.93M | 0.00% | 0.00% | 0.00% | -1673.30% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | -11.86% | -39.34% | -22.53% | -16.34% |
Operating Margin
-27.7%
Net Profit Margin
-65.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -21.55% |
| 2026-03-31 | -19.54% |
| 2025-12-31 | -178.91% |
| 2025-09-30 | -39.22% |
| 2025-06-30 | -13.87% |
| 2025-03-31 | -9.79% |
| 2024-12-31 | -2.70% |
| 2024-09-30 | 3.96% |
| 2024-06-30 | 3.96% |
| 2024-03-31 | 5.84% |
| 2023-12-31 | 3.80% |
| 2023-09-30 | 2.55% |
| 2023-06-30 | -1.60% |
| 2023-03-31 | -3.07% |
| 2022-12-31 | 7.41% |
| 2022-09-30 | 3.02% |
| 2022-06-30 | 11.63% |
| 2022-03-31 | 9.02% |
| 2021-12-31 | 19.42% |
| 2021-09-30 | 4.09% |
| 2021-06-30 | -2.65% |
| 2021-03-31 | -3.38% |
| 2020-12-31 | -14.38% |
| 2020-09-30 | -8.90% |
| 2020-06-30 | -9.08% |
| 2020-03-31 | -45.13% |
